CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 10 enrolled
Drug / intervention
Marijuana +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03699540
NCT03699540Phase 1Completed

Marijuana Effects on Simulated Driving Performance

Shanna Babalonis, PhD·interventional·Posted Oct 9, 2018·Updated Jul 31, 2024

In Brief

A Phase 1 clinical trial evaluating Marijuana, Alcohol, and 2 other interventions for Cannabis and 4 related conditions. Completed, enrolled 10 participants across 1 site.

Detailed Summary

This study will examine the effects of various strains of marijuana on simulated driving performance; the effects of alcohol administration will also be examined to further understand how marijuana-induced driving changes compare to the effects of alcohol. Secondary outcomes will include physiological effects, subjective- and observer-rated outcomes, and psychomotor performance under the various dose conditions.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 1CompletedFinished
20192020202120222023202420252026
First PostedOct 9, 2018
Enrollment StartJul 1, 2019
Primary CompletionDec 1, 2022
Study CompletionJan 1, 2023
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 7.7 years ago

Interventions

Marijuanadrug

Experimental, non-therapeutic administration of active marijuana dose(s)

Alcoholdrug

Experimental, non-therapeutic administration of active alcohol dose(s)

placebo alcoholdrug

Experimental, non-therapeutic administration of inactive alcohol dose(s)

Inactive marijuanadrug

Experimental, non-therapeutic administration of inactive marijuana dose(s)